dermtech 2_0 logo
Elevating dermatologic care with non-invasive skin genomics.

DermTech 2.0 is a platform technology company that provides genomic analysis of skin samples collected non-invasively using its proprietary Smart Sticker®. DermTech 2.0 develops and markets products, including the DermTech Melanoma Test, to facilitate the assessment of melanoma and other skin diseases, and offers DermTech Stratum, precision biomarker services for biopharmaceutical and research partners.

The DermTech Melanoma Test (DMT)

DermTech Stratum

The DMT in Dermatology

The DMT is primarily used by dermatology specialists for the assessment of equivocal pigmented lesions.

Stratum Biopharma Services

Partnering services make the Smart Sticker® platform, high-complexity CLIA laboratory and DermTech 2.0’s expertise available to biopharma partners and central laboratories.

The DMT in Primary Care

The DMT is also available to qualified primary care physicians as a rule-out test to guide dermatology specialty referrals.

Stratum Development

Internal and partnered development of non-invasive genomic tests for indications including Cutaneous T-Cell Lymphoma, Basal Cell Carcinoma, atopic dermatitis, psoriasis and psoriatic arthritis, and the Luminate UV skin damage test.

The DermTech Melanoma Test (DMT)

The DMT in Dermatology

The DMT is primarily used by dermatology specialists for the assessment of equivocal pigmented lesions.

The DMT in Primary Care

The DMT is also available to qualified primary care physicians as a rule-out test to guide dermatology specialty referrals.

DermTech Stratum

Stratum Biopharma Services

Partnering services make the Smart Sticker® platform, high-complexity CLIA laboratory and DermTech 2.0’s expertise available to biopharma partners and central laboratories.

Stratum Development

Internal and partnered development of non-invasive genomic tests for indications including Cutaneous T-Cell Lymphoma, Basal Cell Carcinoma, atopic dermatitis, psoriasis and psoriatic arthritis, and the Luminate UV skin damage test.

Dedicated to laboratory excellence and committed to quality.

Led by a dedicated team of dermatologists, dermatopathologists and experienced laboratory professionals, DermTech 2.0 is committed to quality and customer support.

Led by a dedicated team of dermatologists, dermatopathologists and experienced laboratory professionals, DermTech 2.0 is committed to quality and customer support.
Our Mission is to elevate dermatologic care through noninvasive genomic diagnostics that empower clinicians to best serve their patients.

The innovative DermTech 2.0 Lab is CLIA certified, JCO accredited, and licensed by the New York State Department of Health.

The Joint Commission
CLIA